Monuvir200 mg
Eskayef Bangladesh Ltd.
৳500.00
Out Of Stock
Generic medicine
Molnupiravir: Brands, Price & Uses in Bangladesh
Molnupiravir is an oral antiviral medicine used against SARS-CoV-2 (the virus that causes COVID-19).
About Molnupiravir
Indications of Molnupiravir
Molnupiravir is an oral antiviral medicine used against SARS-CoV-2 (the virus that causes COVID-19).
Established / Authorized Use
- Treatment of mild-to-moderate COVID-19 in adults who have a positive SARS-CoV-2 test result and who are at high risk of progression to severe disease, including hospitalization or death, when authorized alternative treatment options are not accessible or clinically appropriate. Molnupiravir is authorized for this use under emergency-use style regulatory pathways in a number of jurisdictions (including Bangladesh's DGDA and other regulators), rather than under full standard marketing approval in most countries.
- Treatment should be started as early as possible after symptom onset or a positive test, within the label-specified window (generally within 5 days of symptom onset), since effectiveness is greatest with early initiation.
Not Indicated / Not Authorized
- Molnupiravir is not authorized for pre-exposure or post-exposure prophylaxis (prevention) of COVID-19.
- Molnupiravir is not authorized for initiation of treatment in patients hospitalized due to severe or critical COVID-19.
- Molnupiravir is not a substitute for vaccination against COVID-19.
As part of appropriate antiviral stewardship, Molnupiravir should be reserved for the authorized at-risk population and should not be used routinely for all COVID-19 cases.
Dosage & Administration of Molnupiravir
Adult Dose (COVID-19)
| Indication | Dose | Duration |
|---|---|---|
| Mild-to-moderate COVID-19 in eligible at-risk adults | 800 mg (four 200 mg capsules) taken orally every 12 hours | 5 days |
Start treatment as soon as possible after diagnosis and within 5 days of symptom onset. If a dose is missed, it should be taken as soon as possible; if it is close to the time of the next scheduled dose, the missed dose should be skipped - do not double the dose.
Pediatric Dose
Not applicable - Molnupiravir is not authorized for use in patients under 18 years of age (see Use in Special Populations).
Renal/Hepatic Adjustment
No dose adjustment is considered necessary based on available data in mild-to-moderate renal or hepatic impairment; data in severe renal or hepatic impairment are limited (see Use in Special Populations).
Antiviral stewardship: Take Molnupiravir exactly as prescribed by a physician for the full 5-day course; do not stop early, extend the course, skip doses, or share this medicine with others without medical advice.
Side Effects of Molnupiravir
Molnupiravir is generally well tolerated over its short 5-day course. Reported side effects include:
Common
- Diarrhea
- Nausea
- Dizziness
- Headache
Less Common
- Skin rash or urticaria (hives)
- Mild elevations in liver enzymes
Seek prompt medical advice if severe or persistent symptoms, or signs of an allergic reaction, occur while taking Molnupiravir.
Contraindications of Molnupiravir
- Known hypersensitivity to Molnupiravir or to any component of the formulation is the primary absolute contraindication.
- Molnupiravir is not authorized for use in patients under 18 years of age, because it may affect bone and cartilage growth (see Pediatric Uses).
Molnupiravir is not recommended during pregnancy - see Pregnancy and Lactation for details, as this reflects a cautious risk-based recommendation rather than an absolute contraindication.
Frequently Asked Questions about Molnupiravir
What is Molnupiravir used for?
Molnupiravir is an oral antiviral medicine authorized for treating mild-to-moderate COVID-19 in adults who are at high risk of progressing to severe disease, when started early after symptom onset or a positive test.
Can Molnupiravir be used to prevent COVID-19?
No. Molnupiravir is not authorized for pre-exposure or post-exposure prevention (prophylaxis) of COVID-19; it is only authorized for treating an existing infection in eligible at-risk adults.
Can I take Molnupiravir during pregnancy?
Molnupiravir is not recommended during pregnancy because animal studies showed potential harm to the fetus. It should be used in pregnancy only if a physician decides the benefit clearly outweighs the risk, and effective contraception is advised during and for some time after treatment for those who can become pregnant.
Is Molnupiravir safe for children?
No. Molnupiravir is not authorized for anyone under 18 years of age, because it may affect bone and cartilage growth in young people. Safety and efficacy in children have not been established.
Does Molnupiravir replace COVID-19 vaccination?
No. Molnupiravir is not a substitute for vaccination. Vaccination remains the primary way to prevent severe COVID-19, and Molnupiravir is only a treatment option for eligible at-risk adults who already have an active infection.
What should I do if I miss a dose of Molnupiravir?
Take the missed dose of Molnupiravir as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue your normal schedule - do not take a double dose. Complete the full 5-day course as prescribed.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.